InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications. Research title with ★ indicates InBody recommended paper.
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
Endocrinology
Author
S Yagi et al.
Full text